Evidence map›Paper›PMID 37220212›Full record

ArticleACS macro letters2023

Branch Unit Distribution Matters for Gene Delivery.

Yinghao Li, Zhonglei He, Xianqing Wang, Zishan Li, Melissa Johnson, Ruth Foley, A Sigen, Jing Lyu, Wenxin Wang

Abstract read
In one paragraph

Article in ACS macro letters, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Tissue-specific gene delivery approaches.Bioengineering & translational medicine · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yinghao LiCharles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland, D04 V1W8.
Zhonglei HeCharles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland, D04 V1W8.
Xianqing WangCharles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland, D04 V1W8.
Zishan LiCharles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland, D04 V1W8.
Melissa JohnsonCharles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland, D04 V1W8.ORCID 0000-0002-6346-0309
Ruth FoleyCharles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland, D04 V1W8.
A SigenCharles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland, D04 V1W8.
Jing LyuCharles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland, D04 V1W8.ORCID 0000-0001-8886-3289
Wenxin WangCharles Institute of Dermatology, School of Medicine, University College Dublin, Dublin 4, Ireland, D04 V1W8.ORCID 0000-0002-5053-0611

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a key nonviral gene therapy vector, poly(β-amino ester) (PAE) has demonstrated great potential for clinical application after two decades of development. However, even after extensive efforts in structural optimizations, including screening chemical composition, molecular weight (MW), terminal groups, and topology, their DNA delivery efficiency still lags behind that of viral vectors. To break through this bottleneck, in this work, a thorough investigation of highly branched PAEs (HPAEs) was conducted to correlate their fundamental internal structure with their gene transfection performance. We show that an essential structural factor, branch unit distribution (BUD), plays an important role for HPAE transfection capability and that HPAEs with a more uniform distribution of branch units display better transfection efficacy. By optimizing BUD, a high-efficiency HPAE that surpasses well-known commercial reagents (e.g., Lipofectamine 3000 (Lipo3000), jetPEI, and Xfect) can be generated. This work opens an avenue for the structural control and molecular design of high-performance PAE gene delivery vectors.

Indexed as

Gene Transfer TechniquesPolymersGenetic TherapyGenetic VectorsTransfectionPolymers

Identifiers

PMID37220212
PMCPMC10286303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.